Neudle.com: multiple sclerosis primary progressive

Differential
(Click to cross reference)

abducens nerve paralysis

abscess, intracerebral

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acute disseminated encephalomyelitis

acute necrotizing encephalitis

adenylate kinase 5 autoantibodies

adverse drug reaction

affect, flat

Alexanders disease

Alexanders disease, adult onset

amphiphysin antibodies

amyloid angiopathy, cerebral

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis, work up

aneurysm

aneurysm, cavernous sinus

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

anti Hu antibody

antibiotics

antihistamines

arterial dissection, aorta

arteriovenous malformation

arteriovenous malformation, cerebral

autoimmune cerebellar ataxia

Barkhof MR criteria for MS

behavioral disorder

Behcet's syndrome

bone marrow biopsy

bone marrow suppression

brain biopsy

brainstem, lesion of

brucellosis, nervous system involvement with

Brudzinski's sign

carbon monoxide poisoning

CAT scan, emission, abnormal

CAT scan, serial

cavernous sinus, syndrome

central nervous system, infection of

central pontine myelinolysis

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellar pontine angle tumor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral infarction

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular disease

cervical rib

cervical spine

cervical spondylosis

cervical spondylosis, differential diagnosis of

cervical spondylosis, misdiagnosis

chemotherapy, CNS treatment and complications with

Clinical Pathologic Conference(C.P.C.)

clinicoradiologic dissociation

collagen vascular disease

collapsin response mediator protein 5 IgG

complications

concentric sclerosis

confusion

contactin associated protein like 2 antibodies

controversies in neurology

cop 1

corpus callosum

corpus callosum, infarction of

corpus callosum, lesion of

corpus callosum, neoplasm of

cortical blindness

cost effectiveness

cranial neuropathy

cranial neuropathy, multiple

crying, pathologic

cryptococcal meningitis

cyclophosphamide

cyclosporine

cytomegalovirus infection

degenerative diseases of CNS

delirium

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dermatomyositis

diabetes mellitus

diarrhea

differential diagnosis

diffuse axonal injury

disability rating scale, neurological

disability, neurological

disease modifying agents

drug abuse

drug induced neurologic disorders

dysarthria

dysphagia

efficacy

electroencephalogram, abnormalities of

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

epidemiology of neurology

facial weakness, bilateral

gammaglobulin therapy, intravenous

genu of corpus callosum

glioblastoma multiforme(astrocytoma Gr.III)

glioma

gliomatosis cerebri

glutamic acid decarboxylase, antibody

gray matter

Guillain Barre syndrome

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes simplex virus

herpes virus infection

herpes zoster

heterochromia iridis

highly active antiretroviral therapy

hippocampal atrophy

hippocampus

hippocampus, hyperintense

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

Horner's syndrome

Horner's syndrome, etiologies of

human immunodeficiency virus type 1

hydrocephalus

hyperreflexia

hypertension

hypertensive encephalopathy

iatrogenic neurologic disorders

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

intellectual deterioration

interferon

interferon beta 1-a

interferon beta 1-b

intracerebral hemorrhage

Jakob-Creutzfeldt disease

JC virus

Kernig's sign

Klumpke palsy

laminectomy, cervical

laughing, pathologic

leucine rich glioma inactivated 1 antibodies

leukodystrophy

leukoencephalopathy

leukoencephalopathy, differential diagnosis

levamisole

level of consciousness, decreased

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

malformation, vascular, cerebral

malignancy screen

malignancy, occult

Marchiafava-Bignami disease

memory, defect of recent

memory, impairment of

mental status, abnormal

mesial temporal lobe

methotrexate

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

miosis

misdiagnosis

mitochondrial disease

mitoxantrone

monoclonal antibodies

mononeuropathy

mononeuropathy multiplex

motor neuron disease

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

multiple sclerosis, benign form of

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

myasthenia gravis, paraneoplastic

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic examination

neurologic practice

neurologic signs

neuromuscular junction

neuronal cell surface antigen

neuronopathy, sensory

neuropathology

neuropathy

neuropathy, paraneoplastic

neuropathy, sensory

NMDA antagonists

ocrelizumab

onconeural antibodies

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

otitis, neurologic complications with

palatal myoclonus

pancoast tumor

paraneoplastic cerebellar degeneration

paraparesis

paraparesis, spastic

paraproteinemia

paratrigeminal syndrome

peripheral nerve, lesion of

PLEDs, bilateral independent

PLEDs, etiology of

pleocytosis of cerebrospinal fluid

poliomyelitis

polyneuropathy

posterior inferior cerebellar artery syndrome

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

prosopagnosia

pseudobulbar palsy

psychological testing

psychomotor retardation

pulmonary nodules

pupil

pupil, abnormality in neurologic disorders

pyramidal tract dysfunction

quadriparesis

quadriplegia

quality of life

radiation therapy, CNS treatment and complications with

radiculitis

rapidly progressing neurologic illness

ReBUILD study

Red flags

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

shunt procedure, ventricular

shunt procedure, ventricular-complications of

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spasticity

speech disorder

speech, loss of

spinal cord, compression of

spondylosis

steroid

steroid therapy, CNS treatment and complications with

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

syringomyelia

systemic lupus erythematosus

tau protein

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

Thies's sign

thrombocytopenia

thyroiditis

tongue, impaired movements of

tonsillectomy

toxic encephalopathy

toxoplasmosis, acquired

toxoplasmosis, CNS

transient neurologic deficit

treatment of neurologic disorder

trigeminal neuropathy

trigeminal neuropathy, sensory

tuberculosis

tumor necrosis factor

tumor necrosis factor inhibitor

vaccination, neurologic complications with

vaccine

vasculitides

vasculopathy

vertebral-basilar insufficiency

viral infection

viral infection, CNS

viral infection, reactivation

visual evoked response

visual loss

Waldenstrom's macroglobulinemia

walking, difficulty with

white matter, dirty-appearing

workup

xerophthalmia

xerostomia

Showing articles 1350 to 1400 of 9318 << Previous Next >>

Prognosis in Amyotrophic Lateral Sclerosis
Neurol 60:813-819, del Aguila,M.A.,et al, 2003

Neuromyelitis Optica:What It Is and What It Might Be
Lancet 361:889-890, Weinshenker,B.G., 2003

Early or Late Appearance of "Dropped Head Syndrome" in Amyotropic Lateral Sclerosis
JNNP 74:683-686, Gourie-Devi,M.,et al, 2003

New T2 Lesions Enable an Earlier Diagnosis of Multiple Sclerosis in Clinically Isolated Syndromes
Ann Neurol 53:673-676, Dalton,C.M.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Primary Lateral Sclerosis
Neurol 60:1258-1265, Zhai,P.,et al, 2003

Three Subsequent Single Doses of Gadolinum Chelate for Brain MR Imaging in Multiple Sclerosis
AJNR 24:658-662, Sardanelli,F.,et al, 2003

Neonatal Epileptic Encephalopathy
Lancet 361:1614, Clayton,P.T.,et al, 2003

Validation of Diagnositc Magnetic Resonance Imaging Criteria for Multiple Sclerosis and Response to Interferon B1a
Ann Neurol 53:718-724, Barkhof,F.,et al, 2003

Asymmetric Flaccid Paralysis: A Neuromuscular Presentation of West Nile Virus Infection
Ann Neurol 53:703-710,691, Li,J.,et al, 2003

Pernicious Anemia with Neuropsychiatric Dysfunction in a Patient with Sickle Cell Anemia Treated with Folate Supplementation
NEJM 348:2204-2207, Dhar,M.,et al, 2003

Acupuncture in Clinical Neurology
The Neurologist 9:137-148, Rabinstein,A.A. &Shulman,L.M., 2003

Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

Spectrum of Paraneoplastic Neurologic Disorders in Women with Breast and Gynecologic Cancer
Medicine 82:216-223, Rojas-Marcos,I.,et al, 2003

The Outcome of Neurology Outpatients with Medically Unexplained Symptoms: A Prospective Cohort Study
JNNP 74:897-900,842, Carson,A.J.,et al, 2003

Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003

A Randomized Controlled Study of the Acute and Chronic Effects of Cooling Therapy for MS
Neurol 60:1955-1960, NASA/MS Cooling Study Group, 2003

Kennedy Disease
Arch Neurol 60:893-894, Paparounas,K.,et al, 2003

Clinicopath Conf., Giant-Cell Arteritis
NEJM 349:170-180, Case 21-2003, 2003

ALS Patients on TPPV
Neurol 61:135-137, Hayashi,H. &Oppenheimer,E.A., 2003

Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003

Constipation in Neurological Diseases
JNNP 74:13-19, Winge,K.,et al, 2003

New Diagnostic Criteria for Multiple Sclerosis
Neurol 60:27-30,6, Tintore,M.,et al, 2003

Spinal Cord Biopsy: A Review of 38 Cases
Neurosurgery 52:806-816, Cohen-Gadol,A.A.,et al, 2003

Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002

Management of Acute Optic Neuritis
Lancet 360:1953-1962, Hickman,S.J.,et al, 2002

Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002

Course and Prognosis in Early-Onset MS
Neurol 59:1922-1928, Simone,I.L., etla, 2002

Long-Term Durability of Carotid Endarterectomy for Symptomatic Stenosis and Risk Factors for Late Postoperative Stroke
Stroke 33;2658-2663, Cunningham,E.J.,et al, 2002

Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002

A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002

Poliomyelitis Due to West Nile Virus
NEJM 347:1280-1281, Glass,J.D.,et al, 2002

Brain Calcifications in Systemic Sclerosis
Arch Neurol 59:1642-1643, Gusbi,O. &Bernardini,G.L., 2002

Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002

MRI Predictors of Early Conversion to Clinically Definite MS in the CHAMPS Placebo Group
Neurol 59:998-1005, CHAMPS Study Group, 2002

CADASIL Mimicking Primary Angiitis of the Central Nervous System
Arch Neurol 59:1480-1483, Engelter,S.T.,et al, 2002

Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002

Acute Disseminated Encephalomyelitis
Neurol 59:1224-1231, Tenembaum,S.,et al, 2002

Therapy-Related Acute Myeloblastic Leukemia After Mitoxantrone Treatment in a Patient with MS
Neurol 59:954-955, Brassat,D.,et al, 2002

Cardiac Adverse Effects Associated with Mitoxantrone (Novantrone) Therapy in Patients with MS
Neurol 59:909-913, Ghalie,R.G.,et al, 2002

Prognosis for Gross Motor Function in Cerebral Palsy
JAMA 288:1357-1363,1399, Rosenbaum,P.L., et al, 2002

A Blinding Combination
Lancet 360:1220, Matthews,B.N.,et al, 2002

Gluten Sensitivity as a Neurological Illness
JNNP 72:560-563, Hadjivassiliou,M.,et al, 2002

Patients with Multiple Sclerosis and Risk of Type 1 Diabetes Mellitus in Sardinia,Italy: A Cohort Study
Lancet 359:1461-1465,1450, Marrosu,M.G.,et al, 2002

Multiple Sclerosis
Lancet 359:1221-1231, Compston,A. &Coles,A., 2002

Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS
Neurol 58:1404-1407,1323, Killestein,J.,et al, 2002

Results of Radiotherapy for Drooling in Amyotrophic Lateral Sclerosis
Neurol 58:1308, Stalpers,L.J.A. &Moser,E.C., 2002

Efficacy and Safety of Modafinil (Provigil) for the Treatment of Fatigue in Multiple Sclerosis: A Two Centre Phase 2 Study
JNNP 72:179-183,150, Rammohan,K.W.,et al, 2002

Showing articles 1350 to 1400 of 9318 << Previous Next >>